A New Horizon for Breast Cancer: Enhertu Shows Groundbreaking Survival Benefit in HER2-low Metastatic Patients AstraZeneca's Bold Leap: Simplifying US Investment with a Direct Nasdaq Listing European Experts Back Two AstraZeneca Breakthroughs: New Hope for Rare Diseases Trump's Biotech Revolution: Unleashing a Staggering $350 Billion Investment Wave